There are currently three approved CFTR modulator treatments available for CF patients, namely the potentiator Ivacaftor (Kalydeco®) or VX770, the corrector Lumacaftor or VX809 and the corrector Tezacaftor or VX661. Here, CFTR is linked to cystic fibrosis.